within Pharmacolibrary.Drugs.ATC.B;

model B05BA02
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 0.16666666666666666,
    adminDuration  = 600,
    adminMass      = 0.5,
    adminCount     = 1,
    Vd             = 0.00015,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Fat emulsions are sterile preparations of oil-in-water emulsions, typically composed of purified soybean oil, medium-chain triglycerides, or other fats, stabilized by emulsifiers. They are predominantly used as a source of calories and essential fatty acids in parenteral nutrition for patients unable to intake food orally or enterally. Fat emulsions are approved and widely used in hospital settings for this purpose.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for healthy adult individuals based on typical intravenous administration and general literature about parenteral fat emulsions. No definitive PK modeling publications found for specific formulation under ATC code B05BA02.</p><h4>References</h4><ol><li><p>Calkins, KL, et al., &amp; Gura, K (2019). The evolving use of intravenous lipid emulsions in the neonatal intensive care unit. <i>Seminars in perinatology</i> 43(7) 151155–None. DOI:<a href=&quot;https://doi.org/10.1053/j.semperi.2019.06.003&quot;>10.1053/j.semperi.2019.06.003</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/31331633/&quot;>https://pubmed.ncbi.nlm.nih.gov/31331633</a></p></li><li><p>Heavner, JE (2007). Local anesthetics. <i>Current opinion in anaesthesiology</i> 20(4) 336–342. DOI:<a href=&quot;https://doi.org/10.1097/ACO.0b013e3281c10a08&quot;>10.1097/ACO.0b013e3281c10a08</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/17620842/&quot;>https://pubmed.ncbi.nlm.nih.gov/17620842</a></p></li><li><p>Cox, EH, et al., &amp; Danhof, M (1998). Influence of different fat emulsion-based intravenous formulations on the pharmacokinetics and pharmacodynamics of propofol. <i>Pharmaceutical research</i> 15(3) 442–448. DOI:<a href=&quot;https://doi.org/10.1023/a:1011980432646&quot;>10.1023/a:1011980432646</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/9563075/&quot;>https://pubmed.ncbi.nlm.nih.gov/9563075</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end B05BA02;
